Curascript, (1)uptravi 200MCG 140 tab+800MCGX60TB TT PK

Ended Awarded Last action

Contract number
15B50526F00000184
Awardee
Awarding agency
Obligated
$50,215

Award facts

Contract value 100% obligated
$50,214.51 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Titusville, Hopewell Township, NJ 08560, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$45,193
Original award $95,408

About this award

Federal Medical Center Carswell issued a $50,214.51 delivery order to Actelion Pharmaceuticals US, Inc. on July 1, 2026, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for Uptravi tablets and combination packs.

The order is a firm fixed-price call against the GSA schedule. Place of performance is Titusville, Hopewell Township, NJ. The order is due for ultimate completion on September 30, 2026. No set-aside was applied.

Quick answers

Who was awarded contract 15B50526F00000184?

15B50526F00000184 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Medical Center Carswell (Correctional Facilities) on July 1, 2026.

How much is contract 15B50526F00000184 worth?

The government has obligated $50,215 on 15B50526F00000184.

Is contract 15B50526F00000184 an order under another contract?

Yes. 15B50526F00000184 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B50526F00000184 competed?

The extent of competition for 15B50526F00000184 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award